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Introduction
One of the challenges in modern cell biology is how to reveal 
proteomic changes that underlie cellular perturbations, e.g., 
from gene mutation, RNAi, or chemical inhibition. Rapid iden-
tification of the members of protein complexes in a quantitative 
manner would facilitate these types of experiments. Affinity 
purification (AP) of proteins in combination with mass spec-
trometric detection of bound proteins (AP mass spectrometry 
[AP-MS]) identifies the components of protein complexes 
(Gingras et al., 2007; Köcher and Superti-Furga, 2007). AP-MS 
has already been the basis of large-scale interaction mapping in 
Saccharomyces cerevisiae (Gavin et al., 2006; Krogan et al., 
2006). However, it has suffered from two principal problems. 
First, it is difficult to distinguish true interactors from back-
ground. Proteins binding nonspecifically to the antibodies or 
beads always copurify with the specific interactors. This either 
results in a high rate of false-positive interactions or it requires 
stringent purification, such as by tandem affinity tagging (Rigaut 
et al., 1999), often leading to loss of weak and transient binders. 
Second, although the prey proteins are expressed under native 
conditions, in tissue culture, the tagged bait protein is usually 
overexpressed from a cDNA under a general promoter, poten-
tially compromising interaction data. For example, it would 
be very interesting to study how multiple protein complexes 
change with phenotypic perturbation, but such data would be 
difficult to interpret when not expressing the bait under endog-
enous control.
Bacterial artificial chromosome (BAC) recombineering 
(Zhang et al., 1998) is an alternative method to create the bait 
proteins needed for interaction proteomics. In this study, a gene 
of interest in its genomic context is tagged with a construct con-
taining, e.g., GFP (Kittler et al., 2005). The BAC transgene can 
then be stably transfected into mammalian cell lines of choice. 
This allows for expression of the tagged protein at endogenous 
levels and ensures cell type–specific processing and regulation. 
P
rotein interactions are involved in all cellular pro­
cesses. Their efficient and reliable characterization 
is therefore essential for understanding biological 
mechanisms. In this study, we show that combining bac­
terial artificial chromosome (BAC) TransgeneOmics with 
quantitative interaction proteomics, which we call quanti­
tative BAC–green fluorescent protein interactomics (QUBIC), 
allows specific and highly sensitive detection of inter­
actions using rapid, generic, and quantitative proce­
dures with minimal material. We applied this approach 
to identify known and novel components of well­studied 
complexes such as the anaphase­promoting complex. 
Furthermore, we demonstrate second generation inter­
action proteomics by incorporating directed mutational 
transgene modification and drug perturbation into QUBIC. 
These methods identified domain/isoform­specific inter­
actors of pericentrin­ and phosphorylation­specific inter­
actors of TACC3, which are necessary for its recruitment 
to mitotic spindles. The scalability, simplicity, cost effec­
tiveness, and sensitivity of this method provide a basis for 
its general use in small­scale experiments and in mapping 
the human protein interactome.
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precoupled monoclonal mouse anti-GFP antibody. We compared 
different ways to release bound interacting proteins, including 
specific enzymatic elution, unspecific elution with 8 M urea, and 
a newly developed, very efficient in-column digestion proce-
dure with trypsin. We determined that specific protease cleav-
age between bait and GFP tag worked efficiently for a subset of 
baits but poorly for others. For example, when purifying the 
transcription/export (TREX) complex with THOC3 as bait, 
most of the complex components were not identified with spe-
cific protease cleavage (PreScission; GE Healthcare; Fig. S1 B). 
We assume that in this case, the cleavage site was shielded by 
the complex. In contrast, direct enzymatic digests of proteins   
in the column provided high and uniform elution efficiency 
and allowed direct analysis of eluted peptides without pro-
tein precipitation.
We optimized all steps of the procedure using a variety of 
GFP-tagged cell lines. The combination of small magnetic 
beads with elution by in-column protease digestion of proteins 
helped to keep the entire pull-down procedure short (2 h including 
cell lysis). True interaction partners could be distinguished from 
background binders present in the immunoprecipitations (IPs) 
by their quantitative ratios. This also allowed the use of low 
stringency wash conditions, helping to retain weak interaction 
partners. We optimized LC gradients and the instrument method 
on our high resolution mass spectrometers for optimal peptide 
identification and quantitation of interaction partners. Our pro-
tocol allows automated analysis of 10 pull-downs per day. We 
also developed bioinformatic analysis procedures for the statis-
tical interpretation of the quantitative pull-down data on the basis 
of the publicly available MaxQuant package (Cox and Mann, 
2008). We found that a 15-cm dish, corresponding to 10
7 cells, 
provides sufficient material for QUBIC. This is at least a factor 
of 10 less than that commonly used in nonquantitative tandem 
AP (TAP)–MS.
Unraveling the interactors of the TREX 
complex using SILAC-QUBIC
We next applied these techniques to the characterization of the 
interaction network centered around the TREX complex (Reed 
and Cheng, 2005). Although mRNA export is similar in yeast and 
humans, the TREX complex is associated with the transcription 
apparatus in yeast and the splicing machinery in humans (Reed 
and Hurt, 2002; Strässer et al., 2002). In humans, the TREX com-
plex consists of a core called the THO complex that is comprised 
of six proteins (THOC1, THOC2, THOC3, THOC5, THOC6, 
and THOC7) and two adaptor proteins (Aly/THOC4 and Bat1/
UAP56; Masuda et al., 2005). The human TREX complex was 
only recently characterized in 2005, and this required ectopic ex-
pression of several complex members, extensive purification, MS, 
and Western blotting (Masuda et al., 2005).
We reasoned that the QUBIC technology might be able to 
define the TREX complex and its interactions in a rapid and ro-
bust manner. We performed GFP pull-downs of its six core mem-
bers (THOC1–3 and THOC5–7) and the coadaptor THOC4/Aly 
from stable cell lines created by BAC TransgeneOmics. Immuno-
precipitating the TREX complex is especially challenging 
because its function involves association with mRNA, which 
BAC TransgeneOmics has been streamlined and can be readily 
performed for large numbers of genes in parallel (Sarov et al., 
2006; Poser et al., 2008). Furthermore, recombineering tech-
nologies allow for the precise manipulation of BAC transgenes. 
For example, sites of protein modification can be mutated, and 
functional consequences can then be carefully analyzed in their 
native context when the endogenous protein is selectively de-
pleted (Bird and Hyman, 2008).
Quantitative interaction proteomics can efficiently dis-
criminate between specific and background binders without re-
sorting to stringent purification procedures (Blagoev et al., 
2003; Ranish et al., 2003; Vermeulen et al., 2008). We reasoned 
that combining this approach with the BAC recombineering 
technology would overcome most of the limitations currently 
associated with protein interaction screens. This strategy would 
avoid artifacts associated with overexpression but without the 
need to generate specific antibodies. Furthermore, by using 
GFP as the affinity tag, it would directly combine sophisticated 
imaging possibilities with quantitative proteomics technology 
(Cheeseman and Desai, 2005; Trinkle-Mulcahy and Lamond, 
2007; Poser et al., 2008). Using quantitative proteomics would 
efficiently discriminate against background binders while pre-
serving weak interactions. We call this technique quantitative 
BAC-GFP interactomics (QUBIC). Accurate quantification can 
be achieved by stable isotope labeling by amino acids in cell 
culture (SILAC; Ong et al., 2002; Mann, 2006). However, QUBIC 
performs as efficiently in label-free format. We demonstrate the 
power of QUBIC in analyzing the changing nature of protein 
complexes and interactions by addressing the long-standing ques-
tion in mitotic spindle assembly of how the spindle protein 
TACC3 is recruited to spindles through its phosphorylation. We 
identified clathrin as a phospho-dependent spindle-associated 
TACC3 interactor, thereby revealing a functional role of clathrin 
in mitosis.
Results
QUBIC is a rapid and efficient method  
to map protein complexes
QUBIC builds on large-scale BAC TransgeneOmics and power-
ful imaging technologies to which it adds an equally powerful 
quantitative protein interaction screening capability (Fig. 1). To 
create a platform for large-scale interaction studies in mamma-
lian cells, we systematically engineered the various steps with a 
view to minimizing cost, time, and material while maximizing 
reproducibility and generic applicability without compromis-
ing sensitivity. Early on, we found that single-step AP was suf-
ficient to define specific interaction partners when coupled to 
SILAC-based quantitative proteomics performed with high res-
olution liquid chromatography (LC) tandem MS (LC-MS/MS) 
on a mass spectrometer instrument (LTQ Orbitrap). Small mag-
netic beads in combination with a flow-through column system 
gave the best results for bait sequence coverage by MS, de-
tection of interaction partners, and robustness while keeping 
background proteins at acceptable levels (Fig. S1 A). The small 
beads provide a large surface to volume ratio and consequently 
favorable binding kinetics as well as short incubation times using 741 Quantitative BAC interactomics • Hubner et al.
is likewise a noncore TREX interactor. Aly/THOC4, another 
adaptor protein, was identified in our pull-downs but not with a 
statistically significant ratio. It is a highly abundant nuclear pro-
tein, often seen as background binder to beads, and is involved 
in many cellular processes, such as acting as a chaperone in the 
dimerization of transcription factors and mRNA processing and 
mRNA export from the nucleus (Virbasius et al., 1999; Reed 
and Cheng, 2005). The pull-down with Aly-GFP led to only 
moderate enrichment of Aly itself because it binds to control 
beads as well. Nevertheless, THOC2, -5, -6, and -7 were enriched 
in the Aly pull-down (Fig. 2 C). The strongest interaction was 
with THOC5, with which it functionally and physically inter-
acts independently of the TREX complex (Fig. S2 E; Katahira 
et al., 2009).
Below the core and adaptor proteins, there is a cluster com-
prising the entire T complex (TRiC), a chaperone with a role in 
folding nascent, unfolded protein chains (Fig. 2 C). As the T com-
plex is only pulled down with THOC3 and THOC6, we can ex-
clude that it binds to the entire TREX complex. Instead, it is 
likely involved in correct folding of the two proteins before they 
are assembled into the TREX complex.
Lastly, we combined the results of all forward and reverse 
pull-downs into a single graph (Fig. 2 D). By grouping all for-
ward and all reverse pull-downs on the individual components 
in turn associates with numerous RNA-binding proteins. This 
problem was minimized by the nucleic acid digestion step in the 
QUBIC lysis procedure, which prevents coprecipitation of mRNA 
and associated background proteins. SILAC pull-downs were 
performed in forward and reverse format, providing biological 
replicates and separating binders and background by their ra-
tios in two dimensions (Fig. 2, A and B; and Fig. S2). The entire 
complex-mapping experiment required 16 single LC-MS/MS runs 
corresponding to 1.5 d of measurement.
All THOC core components specifically retrieved all other 
THOC core components (forward and reverse pull-down, P < 0.01), 
reliably defining the core complex (Fig. 2, A and B; and Fig S2, 
A–D). GFP fluorescence microscopy was performed in parallel 
on the same cell lines, which verified nuclear localization with 
a characteristic speckled pattern.
Fig. 2 C shows a two-way hierarchical clustering by ratio 
of significant TREX interactors (P < 0.1 in forward and reverse, 
and a ratio >2 for one of the baits). The TREX complex clusters 
at the top of the matrix, and the core members are separated 
from the known adaptor proteins, Bat1, and ARS2 as a result of 
their somewhat lower ratios. ARS2 has been reported as a weak 
and substoichiometric interactor, easily lost during purification 
(Masuda et al., 2005). POLDIP3 is a protein of unknown func-
tion. Its similar pattern in the TREX pull-downs suggests that it 
Figure  1.  QUBIC:  a  method  for  mapping 
protein–protein  interactions  by  combination 
of BAC TransgeneOmics and quantitative MS.   
(A and B) Two optimized AP-MS approaches 
of QUBIC are shown using either SILAC (A) or 
label-free (B) protein quantitation. (A) In SILAC 
experiments, the WT cell line without a BAC 
transgene is cultured in a medium containing 
the C
12N
14 form of lysine, and the tagged cell 
line  is  cultured  in  a  medium  containing  the 
C
13N
15  form  of  lysine.  Separate  pull-downs 
using  magnetic  beads  coupled  to  anti-GFP 
antibody  are  performed,  and  elutes  merged 
directly  after  elution  by  in-column  digestion. 
Peptides  are  identified  by  high  resolution   
LC-MS/MS and quantified by directly compar-
ing relative intensities of the light and heavy 
forms  of  each  peptide  present  in  the  mass 
spectrum.  Specific  interaction  partners  show 
high  H/L  ratios,  whereas  background  bind-
ers have a ratio of 1. (B) In label-free experi-
ments, tagged and control cells are cultured in   
normal  media,  and  separate  pull-downs  are 
performed.  Eluates  are  not  mixed  but  ana-
lyzed separately by LC-MS/MS. Proteins are 
quantified with the label-free algorithm in Max-
Quant software.JCB • VOLUME 189 • NUMBER 4 • 2010   742
Figure 2.  SILAC pull-downs of the TREX core components. (A and B) Results of THOC2 (A) and THOC6 (B) analysis are shown. The GFP-tagged protein, 
serving as bait, is indicated in the title. Annotated proteins marked by a black dot were more abundant in the pull-down of the tagged cell line, with   
P < 0.01 in both the forward and reverse experiments. Blue dots represent proteins that were not significant interaction partners. (top left) Fluorescence 
microscopy was performed on fixed samples of the indicated cell line with anti-GFP antibodies (green), -tubulin antibodies (red), and DAPI (blue). (bottom 
right) Anti-GFP staining only is shown. (C) Two-way hierarchical clustering of specific TREX interactors. Proteins with a ratio >2 and P < 0.1 in the forward 
and reverse experiments of one of the pull-downs served as dataset for clustering (vertical direction). The color code represents the multiplied ratios of the 
forward and multiplied inverted ratios of the reverse experiment in log scale. Blue indicates proteins with a ratio <1 or no ratio, and red indicates proteins 
with extremely high ratios. The first cluster represents the TREX complex, and adaptor proteins are separated from the core by the tree. The T complex 
clusters are shown below the TREX. Furthermore, several proteins binding to all TREX components, but with a lower ratio (yellow), have been identified 
(TREX-associated proteins). Proteins identified with very low ratios in only one of the IPs (bottom of clustering) are likely to be contaminants. (D) Pull-downs 
of all forward and reverse experiments have been treated as a single experiment, and forward were plotted against reverse experiments. TREX core and   
T complex are clear outliers as well as all TREX adaptors identified by the clustering. DDX39, a known interactor of the TREX complex, also shows a signifi-
cant ratio in the combined analysis (Fig. S1). Bars, 10 µm.743 Quantitative BAC interactomics • Hubner et al.
separating binders from background in the fold change versus   
p-value plane (Fig. 3 B). All detectable members of APC and the 
known adaptors CDC20 and FZR1 were clearly inside the accepted 
area with a false-positive rate <0.001.
In addition, we found FBXO5/EMI1, a reported interactor 
of APC and of these adaptor proteins (Miller et al., 2006). Inter-
estingly, NEK2, a serine/threonine protein kinase involved in 
mitotic regulation, was also a significant interactor. NEK2 con-
tains a KEN box through which it is targeted for destruction by 
the APC (Pfleger and Kirschner, 2000). We were intrigued by two 
novel and completely uncharacterized APC binders, both quanti-
fied with >100-fold ratios. C10orf104/ANAPC16 (11.7 kD) was 
detected with P = 1.4 × 10
5, and C11orf51 (14.3 kD) with P = 
1.4 × 10
4. They may have escaped detection by gel-based 
methods because of their small size. One of the proteins, C10orf104/
ANAPC16, was identified in parallel studies as a genuine member 
of the APC core complex (Hutchins et al., 2010; Kops et al., 2010). 
C11orf51 was also identified by SILAC-QUBIC when using dou-
ble labeling with arginine and lysine combined with tryptic diges-
tion (Fig. S3). Furthermore, when we GFP tagged C11orf51 at 
both the N and C terminus, it showed a similar localization pattern 
to CDC23 in interphase (Fig. 3 C).
QUBIC uncovers proteins mediating 
phosphorylation-dependent targeting  
of TACC3 to the mitotic spindle
We next used QUBIC to investigate an unsolved question in 
mitotic spindle assembly: how does the phosphorylation of TACC3 
by aurora A kinase mediate TACC3 localization to spindles? 
Aurora A regulates several mitotic processes (Barr and Gergely, 
2007). However, how phosphorylation of specific proteins by 
aurora A facilitates the progression through mitosis is largely 
unknown. One relatively well-characterized target of aurora A 
is the protein TACC3, a conserved protein that has established 
roles in mitosis and microtubule dynamics in a variety of organ-
isms (for review see Peset and Vernos, 2008). TACC3 localizes 
into two single experiments, specific interactors of the complex 
are enhanced, whereas background binders are diminished. In-
deed, all proteins annotated as TREX adaptors and several proteins 
annotated as TREX-associated proteins are clearly distinguished 
from background in this virtual pull-down experiment. For ex-
ample, BAT1, POLDIP3, and ARS2 associate more closely with 
the core TREX complex than in the individual pull-downs. Fur-
ther demonstrating the usefulness of this analysis, DDX39 pro-
tein was revealed as a significant interactor, although it was 
not statistically significant in any single pull-downs. DDX39 is 
an RNA helicase, and through its interaction with THOC4 and 
Bat1, is an already known interactor of the TREX complex 
(Pryor et al., 2004).
SILAC and label-free QUBIC of the 
anaphase-promoting complex (APC)
Although SILAC quantification is accurate and reliable, this 
technique requires prior labeling of the cell line under study. Be-
cause the ratios between preys binding to bait and control are 
generally large, we investigated whether label-free quantitation 
could identify complex members with the same confidence. For 
this study, we used the APC and performed, in addition to SILAC 
forward and reverse pull-downs, three pull-downs of unlabeled 
cells with CDC23-GFP as bait. We compared the intensities of 
all proteins with three pull-downs with eluates from beads ex-
posed to untransfected HeLa cell lysates. In contrast to a recently 
published method that uses spectral counting as a proxy for pep-
tide abundance (Sowa et al., 2009), we integrated total signal 
from all peptides from our high resolution MS measurements 
using the MaxQuant platform (Cox and Mann, 2008; unpublished 
data). By far, the simplest and most robust method to assign statis-
tical significance to pull-down results turned out to be a t test 
comparing the three IPs with the three controls. We accepted pro-
teins based on a combination of this p-value and the observed 
fold change (Tusher et al., 2001). A newly developed soft-
ware package (QUBICvalidator) calculates a significance curve, 
Figure 3.  SILAC and label-free pull-downs of CDC23. (A) SILAC pull-down of CDC23 versus the untagged HeLa cell line. Annotated proteins were specific 
interaction partners of CDC23 with a p-value of ratio significance <0.001. APC core proteins are separated from APC adaptors (CDC20 and FZR1) by   
intensity. (B) Volcano plot representing results of the label-free pull-down of CDC23. The logarithmic ratio of protein intensities in the CDC23/HeLa pull-
downs were plotted against negative logarithmic p-values of the t test performed from triplicates. A hyperbolic curve separates specific CDC23-interacting 
proteins marked in black (red dotted line) from background (blue dots). The known components of the APC (C10orf104/ANAPC16 only recently char-
acterized in parallel studies), several known APC adaptors, and one uncharacterized protein, C11orf51, show a significant ratio in combination with high 
reproducibility (positive log2 ratios). (C) Localization patterns of GFP-tagged CDC23 and the new component C11orf51 in interphase. Bars, 10 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   744
Figure 4.  Label-free pull-downs of TACC3 and TACC3 interaction partners. (A) Live imaging of cells expressing GFP-tagged TACC3 and mCherry-tagged 
-tubulin. DNA was stained with Hoechst. The RNAi-resistant TACC3
WT localizes to the spindles in mitosis after RNAi of endogenous TACC3. (left) Chromo-
some alignment and spindle morphology are shown. (right) The fluorescence signal of GFP-tagged TACC3 is shown. (B–D) Volcano plots representing 
results of the label-free pull-downs of GFP-tagged TACC3, CLTC, and GTSE1. The logarithmic ratios of protein intensities are plotted against negative 
logarithmic p-values of the t test performed from triplicates. The hyperbolic curve separates specifically interacting proteins marked in black (red dotted line) 
from background (blue dots). Names of all proteins specifically interacting are reported in Table S1. (E) Two-way hierarchical clustering of TACC3 and 
specific interactors CLTC, GTSE1, and PIK3C2A. Proteins significant binding in one of the pull-downs served as dataset for clustering (vertical direction). 745 Quantitative BAC interactomics • Hubner et al.
The rapid availability of BAC transgene cell lines allowed 
us to perform reverse IP experiments using CLTC, GTSE1, and 
PIK3C2A as baits. This analysis revealed that these proteins all 
interact with each other and bind to several proteins that were ini-
tially identified as TACC3 interaction partners, including ch-TOG, 
CLINT1, and SEC16A (Fig. 4, C and D; and Fig. S4 A). We clus-
tered specific interaction partners according to their variability in 
the replicate experiments and the ratios between bait and control. 
This uncovered a putative novel complex consisting of clathrin 
heavy and light chain subunits CLTA, CLTB, and CLTC, as well 
as CLINT1, SEC13, SEC16, PICALM, GTSE1, PIK3C2A, and 
ch-TOG (Fig. 4 E). In addition to a different cluster containing 
TACC3-specific interactors (Fig. 4 E, green), we found several 
proteins that interact with CLTC, GTSE1, and PIK3C2A but not 
TACC3 (Fig. 4 E, blue). Many of the proteins in the latter cluster 
are known to be located in clathrin-coated vesicles. This cluster 
likely represents clathrin-associated proteins present in vesi-
cles in mitotic cells (Fig. 4 F) that do not interact with the spindle- 
associated clathrin directly.
The BAC-GFP cell lines allowed us to analyze the mitotic 
localization of putative spindle-associated interactors by fluores-
cence microscopy. We found that the clathrin (CLTC) and GTSE1-
GFP constructs indeed localize to mitotic spindles similar to 
TACC3 (Fig. 4 F), which is consistent with an interaction. We 
next sought to determine through QUBIC whether any of the 
TACC3 interactors would fail to bind TACC3 when it is not 
phosphorylated by aurora A. Such proteins would be candidates 
for targeting TACC3 to spindles. We inhibited aurora A phos-
phorylation of a GFP-tagged TACC3 construct through two 
complementary methods: treating wild-type (WT) TACC3-GFP 
cells with the aurora A inhibitor MLN8054 and generating point 
mutations in conserved aurora A sites in the TACC3-GFP pro-
tein. For the latter, we additionally engineered three point muta-
tions into the siRNA-resistant TACC3
WT construct in conserved 
serines previously shown in Xenopus laevis or human cells   
to be phosphorylated by aurora A (S34A, S552A, and S558A 
[TACC3
AAA]; Kinoshita et al., 2005; LeRoy et al., 2007).
The TACC3
WT construct was not associated with spindles 
after 5 h of treatment with 500 nM MLN8054, which is in agree-
ment with previous results (Fig. 5 A, bottom; LeRoy et al., 2007). 
In a complementary approach, we analyzed our phosphosite-
mutated TACC3
AAA line. RNAi of endogenous TACC3 in the 
TACC3
WT line had no effect on TACC3
WT localization to the spin-
dle, whereas RNAi of endogenous TACC3 in the TACC3
AAA 
line resulted in the loss of TACC3
AAA from the spindle, which 
is similar to MLN8054 treatment (Fig. 5 B). This is consistent 
with previous data that a TACC3 cDNA transgene mutated at 
S558A does not target to mitotic spindles (LeRoy et al., 2007). We 
additionally found that when TACC3
AAA was the only version 
of TACC3  expressed  in  cells,  we  observed  perturbations  in 
to the mitotic spindle and interacts and shares functions with the 
microtubule polymerase ch-TOG/CKAP5 (Gergely et al., 2000, 
2003; Cullen and Ohkura, 2001; Lee et al., 2001). TACC3 also 
interacts with aurora A, which phosphorylates TACC3 on spe-
cific serine residues (Giet et al., 2002; Kinoshita et al., 2005). 
This phosphorylation regulates localization of TACC3 to the 
mitotic spindle, as depletion of aurora A or mutation of aurora A 
phosphorylation sites in TACC3 results in TACC3 mislocalization 
in several systems (Giet et al., 2002; Bellanger and Gönczy, 2003; 
Srayko et al., 2003; Barros et al., 2005; Kinoshita et al., 2005). 
Furthermore, inhibition of aurora A activity with an aurora A– 
specific small molecule inhibitor, MLN8054 (Manfredi et al., 
2007), also delocalizes TACC3 from spindles in human cells 
(LeRoy et al., 2007).
Despite the many studies on TACC3 and aurora A, it is 
still unknown how TACC3 is recruited to mitotic spindles and 
why phosphorylation by aurora A is required. To elucidate the 
molecular mechanisms responsible for aurora A–dependent 
TACC3 targeting to the spindle, we wished to identify the pro-
teins that interact with TACC3 in mitosis and to determine which 
of these interactions was dependent on TACC3 phosphorylation. 
We initially performed QUBIC on a TACC3-GFP cell line to 
identify interacting proteins. To validate the function of the 
TACC3-GFP transgene, and to subsequently combine QUBIC 
with functional RNAi experiments, we first made an RNAi-
resistant TACC3-GFP BAC construct by recombineering based 
mutation of the region targeted by a 21mer siRNA. This con-
struct, in addition to an mCherry–-tubulin–expressing con-
struct, was stably transfected into U2OS cells. The functionality 
of the TACC3-GFP protein was verified by its correct localiza-
tion to mitotic spindles and by the fact that it did not show any 
noticeable phenotype after RNAi of the endogenous TACC3 
(Fig. 4 A). We refer to this line as TACC3
WT.
Because aurora A phosphorylates TACC3 during mitosis 
(Kinoshita et al., 2005), we next immunoprecipitated TACC3 
from mitotically arrested cells to identify interacting proteins. 
TACC3 itself is the most enriched protein in the pull-down 
(Fig. 4 B), and the known interactors aurora A and ch-TOG also 
had significant p-values (P < 0.01). Multiple novel interactors 
were also identified by QUBIC. Interestingly, these included 
three clathrin subunits, CLTA, CLTB, and CLTC, as well as 
PIK3C2A, which associates with clathrins and is involved in mito-
sis (Gaidarov et al., 2001; Didichenko et al., 2003). These results 
are consistent with the finding that clathrin concentrates at the 
spindle apparatus in mitosis and is involved in microtubule sta-
bilization (Okamoto et al., 2000; Royle et al., 2005). The pro-
tein GTSE1 was also recovered as a significant TACC3-binding 
protein. GTSE1 has been reported to localize to interphase micro-
tubules, but its known functions are related to p53 regulation 
(Utrera et al., 1998; Monte et al., 2004).
The color code represents the normalized log2 of ratios multiplied with the negative logarithmic p- values of the t test. Blue fields represent values close to 0, 
and the protein is therefore unlikely to be binding, whereas red fields represent highly specific binders in the distinct pull-down experiment. The first cluster 
represents a novel spindle-associated complex (red). The second cluster represents TACC3-specific interactors (green). The cluster marked in blue mainly 
consists of proteins associated with clathrin-coated vesicles. (F) Fluorescence microscopy showing live GFP fluorescence of TACC3, CLTC, and GTSE1   
C-terminally tagged with GFP by the BAC TransgenOmics standard protocol. Both TACC3 interactors localize to the mitotic spindle. Bars, 10 µm.
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To confirm and expand the spindle localization dependen-
cies of these proteins, we additionally performed RNAi of 
TACC3, CLTC, and GTSE1 in CLTC-GFP and GTSE1-GFP 
cell lines (Fig. 6). We found that depletion of neither GTSE1 
nor TACC3 resulted in mislocalization of CLTC-GFP from 
spindles, which is consistent with our hypothesis that clathrin 
recruits TACC3 to spindles and suggesting that GTSE1 is re-
cruited through clathrin as well. GTSE1 RNAi depleted protein 
levels to <10%, confirming the efficiency of the siRNA used (un-
published data). Conversely, individual RNAi of both TACC3 
and  CLTC  displaced  GTSE1  from  spindles,  suggesting  that 
GTSE1 is recruited downstream of phospho-TACC3 to these 
spindles. These results support a mechanism in which clathrin is 
first recruited to spindles independently of aurora A. Aurora A 
phosphorylation of TACC3 then allows it to interact with clath-
rin and to localize to spindles. In this study, phospho-TACC3 
also recruits GTSE1. For confirmation of this mechanism, 
we next analyzed the localization of these proteins after treat-
ment with the aurora A inhibitor MLN8054. Consistent with the 
aforementioned hypothesis, inhibition of aurora A activity re-
sulted in the mislocalization of TACC3-GFP (Fig. 4 A, bottom;   
LeRoy et al., 2007) and GTSE1-GFP from spindles but not of 
CLTC-GFP (Fig. 6).
Interaction and localization analysis of 
pericentrin isoforms
Pericentrin is a large (>350 kD) conserved protein that localizes 
to centrosomes and the pericentriolar material and is required 
for centrosome function (Doxsey et al., 1994). Mutations in the 
pericentrin gene (PCNT2), including stop, missense, and splice 
site mutations, are linked to the MOPD II and Seckel syndrome 
disorders, which are characterized by dwarfism and microcephaly 
spindle integrity and chromosome alignment (Fig. 5 B). Thus, 
both methods of inhibiting aurora A phosphorylation of TACC3 
led to mislocalization of TACC3 from spindles and defects in 
spindle assembly.
We then used label-free QUBIC to investigate the under-
lying proteomics changes associated with these phosphorylation 
events. We compared interaction partners of TACC3
WT with cells 
treated with aurora A kinase inhibitor or cells expressing the 
TACC3
AAA phosphomutant. When aurora A activity was inhibited 
by MLN8054 treatment, GTSE1 and CLINT1 bound much less 
to TACC3, as did the three clathrin subunits (CLTA, CLTB, and 
CLTC; Fig. 5 C). PIK3C2A, ch-TOG, and SEC16A showed some 
reduced binding, although to a lesser extent, whereas other inter-
actors exhibited no phospho-dependent binding. Comparing 
TACC3
AAA with TACC3
WT interactors confirmed a differential, 
phospho-dependent interaction of GTSE1 and the clathrin sub-
units (Fig. S4 D). Strikingly, all proteins that showed differen-
tial binding to TACC3 upon aurora A kinase inhibitor treatment 
belong to the aforementioned novel complex (Fig. 5 E), whereas 
proteins that did not change clustered separately as TACC3-
specific interactors in the initial pull-down. This suggests that 
members of this putative spindle-associated complex may either 
recruit TACC3 to mitotic spindles after its phosphorylation by 
aurora A or otherwise require this phosphorylation for local-
ization to spindles.
To test whether clathrin or GTSE1 was required to local-
ize TACC3 to spindles, we performed RNAi of CLTC or GTSE1 
in TACC3
WT cells that also stably expressed mCherry–-tubulin. 
RNAi of CLTC but not GTSE1 delocalizes TACC3 from spin-
dles (Fig. 6 D). Thus, clathrin but not GTSE1 targets TACC3 to 
mitotic spindles, which is likely dependent on the phosphoryla-
tion of TACC3.
Figure  5.  Label-free  pull-downs  of  TACC3   
untreated and treated with aurora A inhibitor. 
(A and B) Live imaging of cells expressing GFP-
tagged TACC3 and mCherry-tagged -tubulin. 
DNA was stained with Hoechst. (top) Chromo-
some alignment and spindle morphology are 
shown.  (bottom)  The  fluorescence  signal  of 
GFP-tagged  TACC3  is  shown.  (A)  TACC3
WT 
normally localizes to spindles in untreated cells 
(left) but is mislocalized away from spindles 
after treatment with the aurora A kinase inhibi-
tor  MLN8054,  similar  to  TACC3
AAA  (middle 
and right). Under both MLN8054-treated and 
mutant TACC3 conditions, spindle morphology 
and chromosome alignment are compromised. 
(B) The RNAi-resistant TACC3
AAA mutant does 
not localize to spindles after RNAi of endog-
enous TACC3 (middle and right). (C) Volcano 
plot representing differential binding partners 
of TACC3 in dependence of treatment with 
aurora A kinase inhibitor. The logarithmic ratios 
of protein intensities are plotted against nega-
tive logarithmic p-values of the t test performed 
from  triplicates.  Proteins  binding  specifically 
in either condition are marked in black and 
annotated.  (D)  Localization  of  TACC3  after 
RNAi of phospho-dependent interactors. Cells 
expressing  TACC3
WT  and  mCherry–-tubulin 
were transfected with control (CON), CLTC, or 
GTSE1 siRNAs, and live cells were imaged after 
72 h. TACC3 is mislocalized from spindles after 
CLTC but not GTSE1 RNAi. Bars, 10 µm.747 Quantitative BAC interactomics • Hubner et al.
or Pc-250; see Materials and methods; Fig. 7 A; Flory and Davis, 
2003). Live and fixed imaging of pericentrin
long cells showed 
a localization of pericentrin to centrosomes throughout the cell 
cycle with increased abundance in mitosis (Fig. 7 B, top; Fig. S5; 
and Video 1; Doxsey et al., 1994). In contrast, pericentrin
short 
localized to the cytoplasm in interphase, and as cells entered 
mitosis, it quickly accumulated at centrosomes, persisting through 
metaphase. The centrosomal signal then dropped off rapidly 
as cells completed mitosis. (Fig. 7 B and Video 2). We confirmed 
these results using fixed analysis (Fig. 7 C, arrows). From these 
results, we conclude that centrosome localization in interphase 
depends on the C-terminal region of pericentrin that contains 
the PACT domain.
Previous results have shown that dynein–dynactin sub-
units bind to pericentrin. Triplicate pull-downs of both constructs, 
as well as of an untagged HeLa cell line, revealed common and 
distinct interaction partners by label-free QUBIC and showed 
that all identified dynein–dynactin subunits bound significantly 
(Griffith et al., 2008; Rauch et al., 2008). Our aim was to use 
QUBIC to identify potential differences in binding partners of two 
reported pericentrin splice isoforms, only one of which con-
tains a C-terminal PACT domain that can localize to centrosomes 
(Gillingham and Munro, 2000). The PACT domain is lost in the 
truncated forms of pericentrin found in patients with MOPD II 
and Seckel syndrome (Griffith et al., 2008; Rauch et al., 2008), 
but it is still unclear how the PACT domain recruits pericentrin 
to centrosomes.
We inserted a GFP tag directly before the stop codon of 
the largest and most commonly investigated pericentrin splice 
isoform (frequently termed pericentrin B). We refer to this con-
struct as pericentrin
long. We engineered an additional pericentrin 
BAC construct, which we call pericentrin
short, to express a protein-
GFP construct in which the final 11+ exons (688 amino acids) of 
the PCNT2 gene, including the PACT domain, are removed so 
that the mRNA product should be the same as a previously re-
ported potential pericentrin splice isoform (termed pericentrin A 
Figure 6.  Mitotic spindle localization interdependencies of CLTC, TACC3, and GTSE1 by RNAi and after aurora A inhibition. (A) Live imaging of mitotic cells 
expressing GFP-tagged CLTC, TACC3, or GTSE1 after RNAi (72 h). GTSE1 is mislocalized after CLTC or TACC3 RNAi, TACC3 is mislocalized after CLTC, 
but not GTSE1 RNAi, and CLTC is not mislocalized by either TACC3 or GTSE1 RNAi. Two images of representative cells are shown for each condition. 
(B) Live imaging of mitotic cells expressing GFP-tagged CLTC, TACC3, or GTSE1 after treatment with the aurora A kinase inhibitor MLN8054. Inhibition 
of aurora A activity mislocalizes GTSE1 but not CLTC from the mitotic spindle. Two images of representative cells are shown for each condition. CON, 
control. Bars, 10 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   748
are already known to depend on each other (Haren et al., 2009), 
our QUBIC experiment was the first evidence of a protein–protein 
interaction between these two centrosome proteins. Enhanced 
binding to the short form was surprising because the long form 
should have all domains of the short form. To investigate possi-
ble further differences between the baits, we mapped all identi-
fied pericentrin peptides to both forms (Fig. 8 D). We identified 
91 and 128 peptides from the pericentrin
long and pericentrin
short 
pull-downs, respectively. None of the peptides found in the 
pericentrin
short pull-down mapped to the C-terminal 688–amino acid 
more to pericentrin
long (Fig. 8). PCM-1, a pericentriolar protein 
known to bind pericentrin (Li et al., 2001) and Fam133A, an 
uncharacterized protein of 30 kD, also bound preferentially to 
the pericentrin
long construct (ratio of 3.9, P = 5.7 × 10
3; and 
ratio of 4.6, P = 1.4 × 10
3).
Interestingly, one centrosomal protein, CDK5RAP2/Cep215 
(Graser et al., 2007; Fong et al., 2008; Haren et al., 2009), was 
significantly enriched in the pull-down of the short construct 
(5.7-fold; P = 1.1 × 10
3; Fig. 8, A and C). Although the centro-
somal localization patterns of CDK5RAP2/Cep215 and pericentrin 
Figure 7.  Fluorescence analysis of pericentrin
long and pericentrin
short cell lines. (A) Diagram of pericentrin
long and pericentrin
short BAC constructs. 
Pericentrin
short lacks a 29.5-kb region of genomic DNA present in pericentrin
long, including the PACT domain (red). The green and yellow box represents 
the GFP cassette. (B) Pericentrin
long and pericentrin
short show distinct cell cycle localizations. Still images from videos of GFP fluorescence are shown. (top) 
Pericentrin
long localizes to centrosomes throughout the cell cycle. (bottom) Pericentrin
short only shows centrosomal localization in mitosis. (C) Immunofluores-
cence showing pericentrin
short localization to centrosomes. Mitotic but not interphase centrosomes are stained by anti-GFP (pericentrin
short), whereas anti-
pericentrin antibody labels all centrosomes. Arrows point to the location of interphase centrosomes. (bottom) Enlarged images of the above boxed regions 
are shown, containing two prophase/prometaphase centrosomes and one interphase centrosome. Cells are stained for -tubulin, GFP (pericentrin
short), 
pericentrin, and DNA. Bars, 10 µm.749 Quantitative BAC interactomics • Hubner et al.
beads, leading to favorable kinetics and therefore short incuba-
tion times, increasing the interactor to background ratio. Elu-
tion from the beads is performed by direct in-column enzymatic 
digestion. Among different quantification methods, we found 
that label-free quantification of high resolution MS data using 
the MaxQuant algorithms provided the best separation of back-
ground and specific binders. High resolution MS is an integral 
part of the QUBIC procedure because it leads to accurate quan-
titation of bait pull-down against control pull-down. This effi-
ciently distinguishes specific binders from background proteins, 
even when the latter are of much higher abundance. The QUBIC 
technology has been applied on hundreds of baits in different 
projects in our laboratory and has proven extremely robust with-
out requiring case-specific optimization.
In Table I, we summarize different aspects of the three 
existing major AP-MS approaches, which are based on tagged 
cDNA with TAP purification (Sowa et al., 2009), tagged cDNA 
with single-step purification (Glatter et al., 2009), or purifica-
tion of endogenous protein complexes using specific antibodies 
(Trinkle-Mulcahy and Lamond, 2007), and compare them with 
QUBIC. TAP has been the basis of some of the most successful 
work so far in yeast, but it clearly only works for very stable as-
sociations. QUBIC only requires a small fraction of the large 
amounts of input material required in TAP-tagging approaches. 
Furthermore, the combination of high yields with short purifica-
tion times minimizes the risk of losing weak interactions com-
pared with TAP procedures. The cDNA approach inevitably 
involves ectopic expression of the gene, which can lead to incor-
rect localization (and therefore inappropriate binding) and forced 
interactions that do not occur in vivo. For example, many cDNA 
baits are not naturally expressed at all in the system that is used 
region of pericentrin, confirming its absence from the expressed 
protein. Surprisingly, however, a second region of 500 amino 
acids, directly N terminal to this region, was well represented 
(25 peptides) in the short form but absent in the long form. This 
was unexpected, as the published predominant cDNA, which 
shares the C terminus with the pericentrin
long construct, contains 
these regions. Analysis of the genomic DNA of these cells con-
firmed that the DNA encoding this region was present in both 
constructs. Therefore, we assume that the observed discrepancy 
is the result of cell type–specific splicing or processing events. 
The finding that pericentrin
short contains a region not found in 
pericentrin
long is the likely explanation of the preferential bind-
ing of CDK5RAP2/Cep215 to this construct.
Discussion
Recent developments in functional genomics using procedures 
such as RNAi have revolutionized the study of phenotype by 
scaling up the rate at which these experiments can be performed 
in a genome-wide manner. However, follow-up techniques, which 
map the proteomic changes underlying these phenotypic changes, 
have lagged behind these studies. With QUBIC, we have devel-
oped an effective technology for studying cell biological ques-
tions in the area of protein interactions, which addresses these 
challenges. Our study shows that modern techniques in MS to-
gether with BAC-based recombineering and live cell imaging 
allow rapid and quantitative assessment of members of a protein 
complex and how they change in response to acute chemical or 
mutational perturbations.
The QUBIC procedure described in this study has several 
attractive features. Interactors are captured on nanometer-sized 
Figure 8.  Pull-downs of pericentrin splice iso-
forms. (A–C) Volcano plots representing results 
of the label-free pull-downs of GFP-tagged peri-
centrin
short and pericentrin
long. The logarithmic 
ratio of protein intensities in the pericentrin/
HeLa (A and B) and pericentrin
long/pericentrin
short 
(C) pull-downs were plotted against negative 
logarithmic  p-values  of  the  t  test  performed 
from  triplicates.  (A  and  B)  The  hyperbolic 
curve separates specific pericentrin-interacting 
proteins marked in black (red dotted line) from 
background (blue dots). (C) Proteins binding 
specifically  to  either  form  of  pericentrin  are 
marked in black. The dotted line represents the 
ratio of pericentrin
long/pericentrin
short. (D) Plot-
ted relative intensities of all peptides identified 
from  pericentrin
short  (blue)  and  pericentrin
long 
(red). The N-terminal part of the protein was   
identified in both pull-downs, whereas there is 
a stretch of 500 amino acids unique to the   
pericentrin
short form (green box). The C terminus 
was deleted in pericentrin
short, and therefore, 
peptides from this region were only identified in 
the pull-downs of pericentrin
long (brown box).JCB • VOLUME 189 • NUMBER 4 • 2010   750
rather than expressing a protein from an artificial cDNA construct. 
High resolution MS can then characterize the isoforms expressed 
as shown in this study.
These applications demonstrate that QUBIC provides a 
versatile platform to accommodate second generation functional 
interaction experiments. Importantly, the quantitative nature of 
QUBIC makes it readily compatible with chemical inhibition or 
RNAi depletion, although these techniques often do not achieve 
full penetrance.
Despite the broad capabilities and versatility of QUBIC, 
it can readily be performed by nonspecialist laboratories. For 
BAC TransgeneOmics, BACs can be ordered and processed, 
and stable cell lines were generated according to published pro-
tocols (Zhang et al., 1998; Poser et al., 2008). All other steps 
similarly require only standard laboratory equipment or readily 
available reagents and only knowledge of common biochemical 
procedures. Costs per pull-down are very low. QUBIC does re-
quire access to high resolution MS equipment coupled to high 
performance LC. However, such equipment is increasingly 
accessible, and the MS analyses themselves are relatively stan-
dard. Data analysis can be performed using the freely avail-
able MaxQuant software suite. Thus, any laboratory can select 
genes of interest and perform QUBIC on them in a wide variety 
of formats.
To make it easy for the research community to perform 
QUBIC, we need to create the generic resources involved. This 
includes  the  genome-wide  generation  of  BAC-based  vectors 
consisting of the gene of interest fused 5 or 3 to the GFP-
containing cassette. First, this set of DNA constructs should be 
available as a resource. Second, stable cell lines of at least one 
common model cell line should be generated with these con-
structs and be available to the community. We have already 
streamlined the BAC TransgeneOmics process (Sarov et al., 
2006; Poser et al., 2008). Based on our experience and the fact 
that we have so far created hundreds of stable cell lines, we pre-
dict that scale up to the whole genome is entirely feasible.
to study interactions. The second strategy of using antibodies 
against endogenous proteins is theoretically the best way to de-
fine in vivo interactions. However, it is not scalable, and it com-
pletely depends on the specificity of the antibody.
QUBIC is the only approach that combines the advantages 
of endogenous gene processing and gene expression while still 
retaining scalability. Because it uses BAC-GFP technology, it 
already comes with several desirable features. These include   
a large reagent base, manipulation of the bait by BAC recombineer-
ing, access to large genes that are not contained in cDNA libraries 
(or that are corrupted in those libraries), and of course direct 
coupling to powerful microscopy methods such as 96-well–based 
live cell imaging. The major conceptual advance in QUBIC is 
the extension of methods that were possible only in yeast to the 
mammalian system.
In addition, QUBIC exemplifies how interaction proteomics 
can be used to rapidly study the proteomic changes underly-
ing phenotypic perturbation. By inhibiting phosphorylation of 
TACC3 either by small molecule inhibition of its upstream 
kinase or by point mutation of conserved phosphorylation sites, 
we identified several proteins that preferentially bind aurora A–
phosphorylated TACC3, representing a novel complex associ-
ated with spindles in mitosis. We have identified one member of 
this complex required for the interaction of phosphorylated 
TACC3 with spindles in clathrin heavy chain (CLTC). Clathrin 
targeting of TACC3 to spindles suggests that reported mitotic 
phenotypes associated with clathrin RNAi and the observed 
role of clathrin in microtubule stability (Royle et al., 2005) are 
caused by the mislocalization of TACC3.
We also show that different forms of the protein pericentrin 
interact with different subsets of centrosomal proteins, which 
may explain their divergent localization patterns. Additionally, 
we found that the predominant pericentrin isoform expressed in 
these cells differs from the published cDNA sequence. This re-
sult illustrates a major advantage of using BACs as transgenes 
in that they allow the cell to process the relevant splice isoforms 
Table I.  Strengths and weaknesses of different AP-MS approaches
Strength/weakness Tagged cDNA Specific antibodies
c QUBIC
Single-step purification
a TAP purification
b
Endogenous gene expression level   + +
Endogenous gene processing   + +
Material required +  + +
Transient interactors +  +/ +
True quantification for background  
discrimination
+/ + +/ +
Objective statistical evaluation +/ +/ +/ +
Sensitivity + +/  +
Measurement time +/ +  +
Standard protocol for all baits +/ +/  +
Compatible with imaging methods +/ +/  +
+, fulfilled; +/, partially fulfilled; , not fulfilled. Three common AP-MS strategies are summarized and compared with QUBIC. There are different aspects that facili-
tate reliable and scalable results in MS-based interaction mapping. Before QUBIC, it is possible to meet some but not all of these requirements at the same time.
aSowa et al., 2009.
bGlatter et al., 2009.
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(Invitrogen), respectively. For SILAC labeling, HeLa cells were cultured for 
2 wk in DME (4.5 g/L glucose) without lysine and with methionine (Invitro-
gen) containing 49 mg/ml light (C
12N
14) or heavy (C
13N
15) lysine (Euriso-
Top), 100 U/ml penicillin (Invitrogen), 100 mg/ml streptomycin (Invitrogen), 
and 10% fetal bovine serum dialyzed with a cut off of 10 kD (Invitro-
gen) at 37°C and 5% CO2. The WT cell line was treated the same as   
a control. Cells were harvested using trypsin, washed once with PBS, and 
the pellet was shock frozen in liquid nitrogen and stored at 80°C   
until used for IP.
Specific cell culture of TACC3 cells for QUBIC
For aurora A inhibitor experiments, triplicate experiments each using four 
15-cm dishes of GFP-tagged TACC3 and two 15-cm dishes of U2OS con-
trol cells were seeded to 60% confluence and arrested in mitosis by adding 
2 mM thymidine (Sigma-Aldrich) for 20 h. They were then washed with 
PBS, and fresh media were added. After 6 h, 100 ng/ml nocodazole was 
added, and after an additional 3 h, aurora A kinase inhibitor MLN8054 
(provided by J. Ecsedy, Millennium Pharmaceuticals, Cambridge, MA) was 
added to two TACC3 dishes to a final concentration of 500 nM. 5 h later, 
all cells were harvested.
For TACC3 RNAi of cells before QUBIC analysis, 10
7 cells for each 
condition were resuspended in 8 ml media without antibiotics. Transfection 
complexes containing of 1.8 nmol siRNA and 30 µl Oligofectamine were 
added to cells in a 50-ml tube. Cells were incubated for 6 h at 37°C with 
occasional agitation and plated. 77 h after transfection, nocodazole was 
added to cells for 22 h, at which point cells were harvested for analysis.
IP
Cell pellets were thawed on ice and incubated for 30 min at room tempera-
ture in 1 ml lysis buffer containing 150 mM NaCl, 50 mM Tris, pH 7.5, 5% 
glycerol, 1% IGEPAL-CA-630, 1 mM MgCl2, 200 U benzonase (Merck), 
and EDTA-free complete protease inhibitor cocktail (Roche). When study-
ing phospho-dependent interactions, phosphatase inhibitors (Roche) were 
added as well. Lysates were cleared by centrifugation at 4,000 g and 4°C 
for 15 min to remove remaining membrane and DNA, and the supernatant 
was incubated with 50 µl magnetic beads coupled to monoclonal mouse 
anti-GFP antibody (Miltenyi Biotec) for 15 min on ice. Because of the ex-
tremely small size of the beads (50 nm), they are nonsedimenting and 
show fast reaction kinetics. Magnetic columns were equilibrated using 250 µl 
lysis buffer. Cell lysates were added to the column after incubation and 
washed three times with 800 µl ice-cold wash buffer I containing 150 mM 
NaCl, 50 mM Tris, pH 7.5, 5% glycerol, and 0.05% IGEPAL-CA-630, and 
two times with 500 µl of wash buffer II containing 150 mM NaCl, 50 mM 
Tris, pH 7.5, and 5% glycerol. Purified proteins were predigested by add-
ing 25 µl 2 M urea in 50 mM Tris, pH 7.5, 1 mM DTT, and 150 ng Endo-
LysC (Wako Chemicals USA, Inc.) for SILAC experiments or 150 ng trypsin 
(Promega) for label-free experiments. After in-column digestion for 30 min 
at room temperature, proteins were eluted by adding two times 50 µl 2 M 
urea in 50 mM Tris, pH 7.5, and 5 mM chloroacetamide. In SILAC experi-
ments, heavy and light eluates of transgenic cell line and the correspond-
ing WT cell line were combined immediately after elution from the columns. 
Proteins were digested overnight at room temperature. The digestion was 
stopped by adding 1 µl trifluoroacetic acid, and peptides of each experi-
ment were split and purified on two C18 Stage Tips and stored at 4°C 
(Rappsilber et al., 2007).
Pull-downs can be performed manually on a hand magnet. In our 
laboratory, pull-downs were performed on the automated liquid-handling 
platform (Freedom EVO 200; Tecan) in a fully automated manner.
LC-MS/MS analysis
Peptides were eluted from C18 Stage Tips with 2 × 20 µl solvent B 
(80% acetonitrile and 0.5% acetic acid). Acetonitrile was evaporated, 
and thereby, the volume reduced to 5 µl in a speed vacuum centrifuge. 
10 µl solvent containing 2% acetonitrile and 0.1% trifluoroacetic acid 
was added.
Peptides were separated on line to the mass spectrometer by using 
an easy nano-LC system (Proxeon Biosystems). 5 µl samples were loaded 
with a constant flow of 700 nl/min onto a 15-cm fused silica emitter with an 
inner diameter of 75 µm (IntelliFlow; Proxeon Biosystems) packed in house 
with RP ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch). Peptides were eluted 
with a segmented gradient of 2–60% (for trypsin digest) and 5–60% (for   
EndoLysC digest) solvent B over 105 min with a constant flow of 250 nl/min. 
The nano-LC system was coupled to a mass spectrometer (LTQ-Orbitrap; 
Thermo Fisher Scientific) via a nanoscale LC interface (Proxeon Biosystems). 
The spray voltage was set to 2.1 kV, and the temperature of the heated 
capillary was set to 180°C.
Materials and methods
BAC constructs
BACs containing the gene of interest were purchased from BACPAC Resources 
Center (for detailed information see Supplemental data). A LAP tag cassette 
(Poser et al., 2008) was recombined at the C terminus of all TREX components, 
CDC23, TACC3, CLTC, GTSE1, and PIK3C2A by Red E/T–based recom-
bination (Zhang et al., 1998; Muyrers et al., 2001). Point mutations in 
TACC3 were introduced through recombineering using counter selection 
based on an RpsL-amp cassette (Guo et al., 2006; Bird and Hyman, 2008) as 
described in the Counter Selection BAC Modification kit (Genebridges). For 
the pericentrin
long construct, a GFP tag cassette was recombined at the C termi-
nus of the PCNT2 gene, ending with the amino acid sequence QKIKQ. For the 
pericentrin
short construct, a GFP tag cassette was recombined into the coding 
region of the PCNT gene to directly follow the amino acid sequence QKTLSK, 
while simultaneously deleting all of the following exons until the 3 UTR, so as 
to match the sequence in the 3 end of GenBank accession no. AY179559.
Cell culture and cell lines for BAC transfection
U2OS, HeLa, and HeLa Kyoto cells were grown in DME containing 10% 
fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml 
streptomycin at 37°C and 5% CO2. BAC constructs or an mCherry– 
-tubulin plasmid were transfected into cells in 6-cm dishes with 20 µl Effectene 
(QIAGEN) following the manufacturer’s protocol, and stable line popula-
tions were selected on G418 (BACs) or puromycin. TACC3 constructs were 
used in U2OS cells, pericentrin constructs were used in HeLa cells, and 
CLTC, PIK3C2A, APC members, and TREX members were used in HeLa 
Kyoto cells. GTSE1 constructs for pull-downs were used in HeLa Kyoto cells, 
and for localization after RNAi and inhibitor treatment, were used in U2OS 
cells. For siRNA transfections, cells were added to prewarmed media, and 
transfection complexes containing 2.0 µl Oligofectamine (Invitrogen) and 
80 pmol (TACC3 and control) or 40 pmol (GTSE1, CLTC, and control) 
siRNA added immediately afterward in a total volume of 500 µl. Media 
were changed after 6–8 h. Control (Silencer Negative Control #3), TACC3 
(5-GUUACCGGAAGAUCGUCUG-3), GTSE1 (5-CGGCCUCUGUCA-
AACAUCA-3), and CLTC (5-GGUUGCUCUUGUUACGGAU-3) siRNAs 
were  purchased  from  Applied  Biosystems.  For  MLN8054  experiments, 
cells were treated for 5 h with 500 nM MLN8054.
Antibodies
The following antibodies were used for immunofluorescence: mouse anti–
-tubulin (DM1; Sigma-Aldrich), rat anti–-tubulin (AbD Serotec), rabbit 
anti-pericentrin (Abcam), mouse anti-GFP (Roche), and goat anti-GFP (Poser 
et al., 2008). Secondary antibodies used were donkey anti–mouse, –rabbit, 
or –rat conjugated to Alexa Fluor 488, 594, or 647 (Invitrogen).
Immunofluorescence
Cells on coverslips were fixed with PFA (TREX and APC images) or 20°C 
methanol (pericentrin images). Cells were blocked with 0.2% fish skin gela-
tin (Sigma-Aldrich) in PBS. Cells were incubated with primary antibodies in 
0.2% fish skin gelatin in PBS for 20 min at 37°C, washed, and repeated 
with secondary antibodies. Coverslips were mounted with ProLong gold 
with DAPI (Invitrogen) overnight and sealed.
Microscopy and image quantification
Images of TREX and APC components were acquired using MetaMorph soft-
ware (version 7.1.2.0; MDS Analytical Technologies) on a microscope (Axio-
plan 2; Carl Zeiss, Inc.) with a 63× 1.40 NA oil differential interference 
contrast Plan Apochromat objective (Carl Zeiss, Inc.) and a camera (CA 742–95; 
Hamamatsu Photonics) at room temperature. All other fixed and live images 
were acquired using an imaging system (Deltavision RT; Applied Precision) 
with an inverted microscope (IX70/71; Olympus) equipped with a charge-
coupled device camera (CoolSNAP HQ; Roper Industries). Fixed images were 
acquired in 0.2-µm serial z sections using a 100× 1.35 NA UPlanApo objec-
tive at room temperature. Live cell videos were acquired in 1.5-µm serial   
z sections at intervals of 3 (pericentrin
long) or 15 min (pericentrin
short) using a 
60× 1.42 NA PlanApo N objective at 37°C. For live three-color still images of 
TACC3-GFP mCherry–-tubulin lines, 100 ng/ml Hoechst 33342 was added 
to the media 1 h before imaging. All live cell still images were acquired in 
0.5-µm serial z sections. For live cell imaging, cells were incubated in a   
CO2-independent medium (Invitrogen). Datasets were deconvolved using Soft-
Worx software (Applied Precision).
Cell culture for QUBIC experiments
For all pull-downs, 10
7 cells were used. Stably transfected HeLa and U2OS 
cells were cultured in media containing 400 µg/ml and 500 µg/ml geneticin JCB • VOLUME 189 • NUMBER 4 • 2010   752
for reverse hits and contaminants (Processing – Filter – Filter category –   
Reverse = + and Contaminant = +). Positive intensity values were logarith-
mized (Processing – Transformation – LOG – Log2). Signals that were 
originally zero were imputed with random numbers from a normal distribu-
tion, whose mean and standard deviation were chosen to best simulate low 
abundance values below the noise level (Processing – Imputation – Replace 
missing values by normal distribution – Width = 0.3; Shift = 1.8). Signifi-
cant interactors were determined by a volcano plot-based strategy, com-
bining t test p-values with ratio information. The standard equal group 
variance t test was applied (Processing – Testing – Two groups). Signifi-
cance lines in the volcano plot corresponding to a given FDR were deter-
mined by a permutation-based method (Tusher et al., 2001). The pull-down 
was selected as Group1 and the control as Group2. Threshold values   
(= FDR) were selected between 0.1 and 0.001 and SO values (= curve 
bend) between 0.5 and 2.0. The resulting table was then exported (Export – 
Tab separated). The second tab (Table S1 and Table S2) was selected, and 
values saved with the same file name were supplemented with “_sup” 
(e.g., Exp.txt → Exp_sup.txt). Results were then plotted using the open 
source statistical software R and the provided script QUBIC-LABELFREE.R. 
In the beginning of the script, Exp.txt and Exp_sup.txt have to be re-
placed with the real file names. Dynamic experiments were plotted using 
the script QUBIC-LABELFREE_dynamic.R. Significant TREX and TACC3 
interactors were clustered using Genesis (Sturn et al., 2002).
A detailed step by step protocol and the raw data and programs 
associated  with  this  manuscript  may  be  downloaded  from  https:// 
proteomecommons.org/tranche, launching Tranche, choosing “Open By 
Hash”, and entering the following hash: iNYsECWFuN0KDV0Q8QoE
3uXxRGuBiCo5+iwydOM7h29jlyPv+Xv4+1piRkFr+mcnsy+eErYIvmcRQf
9ZU/l5lxQYNQYAAAAAAABFCA==
Online supplemental material
Fig. S1 shows development of the QUBIC technology. Fig. S2 shows addi-
tional SILAC pull-downs of the TREX complex components. Fig. S3 shows 
an additional SILAC pull-down of CDC23. Fig. S4 shows additional label-
free pull-downs of TACC3. Fig. S5 shows that pericentrin
long GFP colocal-
izes with anti-pericentrin antibody throughout the cell cycle. Table S1 shows 
specific  interaction  partners  of  label-free  pull-downs  of  TACC3,  CLTC, 
GTSE1, and PIK3C2A. Table S2 shows links to the University of California, 
Santa Cruz genome browser for used BACs, BAC length, gene length, 
number, and name of additional genes. Video 1 shows that pericentrin
long 
localizes to centrosomes throughout mitosis and the cell cycle. Video 2 shows 
that pericentrin
short localizes to centrosomes in mitosis but not interphase. 
Supplemental data show step by step QUBIC protocol, QUBICvalidator 
(download at Tranche), and R scripts, including test datasets (download at 
Tranche). Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200911091/DC1.
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